Elliott Management’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CRMD
EIM
CAM
N
Elliott Management's CRMD Position: Q1 2020 in Review
Elliott Management sold out of CorMedix (CRMD) in Q1 2020, closing a stake of 833,374 shares — an estimated $6.07M sold.
Elliott Management first reported a position in CRMD in Q2 2013 and held it in 27 quarters. The position peaked at $14.8M in Q1 2015. 59 funds tracked by Wall St. Rank hold CRMD as of Q1 2020.
- Elliott Management reported no remaining CorMedix position as of Q1 2020 after selling out during the quarter.
- Elliott Management sold 833,374 CorMedix shares in Q1 2020, an estimated $6.07M.
- Elliott Management first reported a position in CorMedix in Q2 2013 and held it in 27 quarters.
- Elliott Management's CorMedix position peaked at $14.8M in Q1 2015.
- 59 funds tracked by Wall St. Rank held CorMedix as of Q1 2020.
Based on Elliott Management's 13F filing for Q1 2020.